Susquehanna International Group, LLP Athersys, Inc Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.18 - $0.86 $4,437 - $21,199
-24,651 Reduced 7.42%
307,757 $80,000
Q1 2022

May 16, 2022
SELL
$0.6 - $1.06 $71,244 - $125,865
-118,741 Reduced 26.32%
332,408 $201,000
Q4 2021

Feb 14, 2022
SELL
$0.85 - $1.4 $111,782 - $184,112
-131,509 Reduced 22.57%
451,149 $407,000
Q3 2021

Nov 15, 2021
SELL
$1.33 - $1.77 $59,165 - $78,738
-44,485 Reduced 7.09%
582,658 $775,000
Q2 2021

Aug 11, 2021
BUY
$1.41 - $1.94 $11,363 - $15,634
8,059 Added 1.3%
627,143 $903,000
Q1 2021

May 17, 2021
BUY
$1.61 - $2.77 $517,671 - $890,651
321,535 Added 108.06%
619,084 $1.11 Million
Q4 2020

Feb 16, 2021
SELL
$1.55 - $2.24 $185,762 - $268,457
-119,847 Reduced 28.71%
297,549 $521,000
Q3 2020

Nov 16, 2020
BUY
$1.91 - $3.08 $303,371 - $489,205
158,833 Added 61.43%
417,396 $814,000
Q2 2020

Aug 14, 2020
BUY
$1.97 - $3.98 $24,705 - $49,913
12,541 Added 5.1%
258,563 $714,000
Q1 2020

May 15, 2020
BUY
$1.17 - $3.0 $171,945 - $440,886
146,962 Added 148.36%
246,022 $738,000
Q4 2019

Feb 14, 2020
SELL
$1.16 - $1.42 $112,203 - $137,352
-96,727 Reduced 49.4%
99,060 $122,000
Q3 2019

Nov 14, 2019
BUY
$1.21 - $1.65 $39,502 - $53,867
32,647 Added 20.01%
195,787 $260,000
Q2 2019

Aug 16, 2019
BUY
$1.39 - $2.03 $33,426 - $48,817
24,048 Added 17.29%
163,140 $274,000
Q2 2019

Aug 14, 2019
SELL
$1.39 - $2.03 $76,259 - $111,371
-54,863 Reduced 28.29%
139,092 $233,000
Q4 2018

Feb 14, 2019
BUY
$1.41 - $2.16 $161,714 - $247,732
114,691 Added 144.69%
193,955 $280,000
Q3 2018

Nov 14, 2018
SELL
$1.86 - $2.18 $200,124 - $234,554
-107,594 Reduced 57.58%
79,264 $166,000
Q4 2017

Feb 14, 2018
BUY
$1.65 - $2.45 $308,315 - $457,802
186,858
186,858 $338,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email